Rhinitus/Sinusitis/Ocular Allergy News

Persistent rhinitis and the presence of both rhinitis and asthma were associated with IgE sensitization and total IgE levels, according to a study published in Clinical and Translational Allergy.

Dupilumab improved outcomes among patients with severe chronic rhinosinusitis with nasal polyps across a range of type 2 inflammatory signatures, according to data presented at EAACI Hybrid Congress 2023 in Hamburg, Germany.

The overall average annual percentage changes in costs for 14 popular rhinology medications outpaced the general annual inflation rate for 5 of 7 years evaluated, according to a study published in Annals of Allergy, Asthma & Immunology.

Information about nutritional treatment for the atopic triad on YouTube tends to be dubious, with a recent study of 91 videos by Høj et al. classifying 65% of them as misleading and only 32% of them as useful.

Women who have been exposed to domestic violence and abuse are at greater risk for asthma, atopic eczema and allergic rhinoconjunctivitis, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice.

People with allergic diseases had an increased risk for cataract surgery, an association more evident in men aged younger than 50 years and in those with both atopic dermatitis and allergic rhinitis, according to data in Scientific Reports.

Neighborhood-level socioeconomic deprivation may play a role in the prevalence of asthma and allergic rhinitis among children with food allergy, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice.

Black and Hispanic patients with allergic rhinitis get fewer prescriptions for subcutaneous immunotherapy compared with white patients, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice.

Allergy immunotherapy is effective in achieving long-term results for allergic rhinitis in real-world treatment, according to a study published in The Journal of Allergy Clinical Immunology.

Early efficacy in treatment may predict clinical response to subcutaneous immunotherapy for allergic rhinitis due to house dust mite allergy at 3 years, according to a letter published in Clinical and Translational Allergy.